Solstice Advanced Materials 3Q26 Earnings Call - SOLSTICE ADVANCED MATERIALS INC

Explicit Guidance:

• Full Year 2026: Net sales raised to $4.195B–$4.22B; Adjusted EBITDA raised to $1.05B–$1.06B; Adjusted Diluted EPS raised to $2.90–$2.95.
• Fourth Quarter 2026: Net sales guidance of $1.01B–$1.035B; Adjusted EBITDA of $246M–$256M; Adjusted EPS of $0.57–$0.62.
• Capital Expenditures (CapEx): Full-year 2026 guidance maintained at $420M–$440M, with a strategic shift to accelerate deployment into 2027–2028 to meet demand.
• Share Repurchases: Intend to substantially complete the remaining $400M (totaling $500M) under the current authorization by the end of Q1 2027.
• Dividends: Committed to annually growing the dividend.

Business-Segment Outlook:

• Nuclear Conversion: Backlog reached $2.6B (contracts extending to 2039) with multiple SMR customers. Production expected to exceed 10,000 tons in 2026, with a pathway to an additional 1,000–2,000 tons via low-cost debottlenecking at the Metropolis facility in 2027. Large-scale expansion evaluation is ongoing; conditional agreements exist for uptake, with a final decision pending further customer commitments and cost refinement.
• Electronic Materials: Sales up 31% YoY; growth driven by sputtering targets and thermal solutions for AI/data centers. Current output at Spokane is constrained; a $200M+ expansion to double capacity is underway, with volume increments expected in 2027 and the majority in 2028. Future expansion conversations (3rd phase) are in early stages.
• Refrigerants & Applied Solutions (RAS): Expects modest YoY growth in Q4 2026, facing headwinds from 454B residential destocking and construction softness. Forecasts market normalization in 2027 as destocking completes and aftermarket demand for 454B matures.
• Healthcare Packaging: Following 24% YoY growth due to post-destocking restocking, expects "mid-single-digit" growth rates (approx. 6% CAGR) moving forward into 2027.
• Data Center Exposure: Representing ~6% of 2026 revenue, with growth >50% YoY. Sales expected to reach $100M from refrigerants and >$150M from electronic materials in 2026.

Market and Competitive Outlook:

• Data Center/AI: Demand remains robust with no signs of slowdown; customers are accelerating procurement of thermal interface materials and sputtering targets.
• Refrigerant Market: 454B residential market faces ongoing destocking through 2026, with a "high single-digit" normalization rate expected for HFOs in 2027.
• Nuclear Market: Demand strengthened by clean baseload power needs, government lending, and the scheduled end of Russian-enriched uranium import waivers (Jan 2028). Global reactor construction is expanding (30+ reactors), indicating capacity needs beyond 2030.
• Pricing Strategy: Maintains ~90% contracted volume and ~10% open spot market capacity for nuclear conversion.

Macro / Industry Outlook:

• Regulatory/Geopolitical: U.S. government requirements for unobligated uranium hexafluoride (UF6) create demand for Metropolis expansion. End of Russian uranium waivers in 2028 is a key structural catalyst for domestic capacity.
• Interest Rates/Capital Environment: Management views current share price as an attractive entry point for buybacks; capital allocation remains disciplined, prioritizing high-return organic projects over transformative M&A.
• R&D Spending: Targeting R&D spend increase from 2% to ~3% of sales to develop next-generation refrigerant molecules and electronics technologies; currently at 2.6%.

Strategic Initiatives:

• Organic Expansion: Accelerating Spokane facility (sputtering targets) and Metropolis debottlenecking to meet near-term demand; pursuing multi-year capacity programs concluding in 2028.
• M&A Stance: No transformational M&A on the horizon; focus remains on "bolt-on" or "tuck-in" acquisitions that strengthen core portfolios if unique opportunities arise.
• Spinoff Optimization: Completed transition of all legacy Honeywell TSAs ahead of schedule and under budget; organization fully focused on standalone operational excellence.

Risks and Headwinds to Outlook:

• Refrigerant Destocking: Continued weakness in 454B residential/HVAC markets in Q4 2026 and potential drag on margins until 2027 normalization.
• Capacity Constraints: Spokane facility currently fully utilized for depositions; equipment lead times and supplier availability could delay acceleration of volume increments.
• Nuclear Expansion Uncertainty: Large-scale capacity decisions remain dependent on securing ~80% customer commitments, final project cost refinement, and DOE alignment.
• Construction Softness: Continued weakness in general construction end markets affecting "Building solutions" segment.
• Lumpiness: Nuclear sales exhibit lumpy order patterns due to long-term project timelines (3–4 years).

Management Tone on the Future:

• Confidence Level: High confidence in the "growth algorithm" and the ability to convert secular trends (AI, nuclear, thermal) into financial performance.
• Execution: Emphasizes "disciplined execution" and "relentless focus" on margin improvement (targeting 25% adjusted EBITDA margin).
• Strategic Shift: Expresses strong conviction in the standalone strategy post-element solutions termination, viewing organic growth and capital return as primary value drivers.

Miscellaneous:

• R&D Impact on Margins: Increased R&D spending for next-gen molecules contributed to RAS margin compression in the quarter but is viewed as necessary for long-term innovation.
• Minority Interest: NCI expected to increase to ~$70M for the full year due to favorable mix and site performance, partially offset by the impact of UF6 loan repayments.
• Cost Control: Corporate costs declined modestly year-over-year, reflecting operational efficiency gains.